Predictive Oncology Inc (POAI) Live Share Price, Invest From India

Predictive Oncology Inc Stock Performance

as on October 22, 2025 at 12:36 am IST

Day's Low
Day's High
$9.26
Day's Price Range
$9.55
$9.35
0.96%
Downside
2.14%
Upside
52 Week's Low
52 Week's High
$9.14
52-Week Price Range
$45.9
$9.35
2.25%
Downside
390.91%
Upside

Predictive Oncology Inc share price movements today

Previous Close: $9.31
Open: $9.45
Volume: 135.8K
Day's Low - High: $9.26 - $9.55
52 Week Low - High: $9.14 - $45.9

Predictive Oncology Inc Historical Returns

1 Month Return: -38.55 %
3 Month Return: -20.95 %
1 Year Return: -6.55 %
3 Year Return: -88.91 %
5 Year Return: -96.22 %

Predictive Oncology Inc Stock Fundamentals & Key Indicators

Check Predictive Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$49.2M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-9.7M

Revenue (TTM)

1.7M

Profit Margin

0.00%

Return On Equity TTM

60417300.00%

Predictive Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Predictive Oncology Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Predictive Oncology Inc	BUY	$49.2M	-96.22%	NA	0.00%
Doximity, Inc.	HOLD	$12.7B	NA	57.75	39.88%
Veeva Systems Inc.	BUY	$46.5B	-3.03%	58.5	27.29%
Ge Healthcare Technologies Inc.	BUY	$33.8B	NA	15.17	11.22%
Tempus Ai	NA	$15.2B	NA	40.83	-20.98%

Stock Returns calculator for Predictive Oncology Inc Stock including INR - Dollar returns

The Predictive Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Predictive Oncology Inc investment value today

Current value as on today

₹98,683

Returns

₹1,317

(-1.32%)

Returns from Predictive Oncology Inc Stock

₹6,124 (-6.12%)

Dollar Returns*

₹4,808 (+4.81%)

Analyst Recommendation on Predictive Oncology Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Predictive Oncology Inc. Average target price of $3

Predictive Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Predictive Oncology Inc.

What analysts predicted

-211.67%DOWNSIDE

Target Price

Current Price

$9.35

Analyzed by

7 Analysts

Target

$3.00

Predictive Oncology Inc target price $3, a slight downside of -211.67% compared to current price of $9.35. According to 7 analysts rating.

Predictive Oncology Inc Stock’s Investor Sentiment and Interest

Investment in Predictive Oncology Inc Shares on INDmoney has grown by 2320.00% over the past 30 days, indicating increased transactional activity.

Time period: September 22, 2025 to October 22, 2025

Change:2320.00% versus previous 30 day period

Search interest for Predictive Oncology Inc Stock has increased by 392% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 22, 2025 to October 22, 2025

Change:392% versus previous 30 day period

Predictive Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-3	-3	-2	-3	-4	-3	-2	-2	-2	-2
EBITDA	-3	-3	-2	-3	-4	-3	-2	-1	-2	-1
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-3	-2	-3	-4	-3	-2	-2	-2	-1
Income Tax Expense	0	0	0	0	0	0	-	0	-	-
Net Income	-4	-3	-3	-3	-4	-3	-3	-2	-2	-2
Net Profit Margin	-1774.58%	-800.51%	-467.53%	-1037.32%	-1005.33%	-1141.37%	-895.23%	-354.75%	-2214.55%	-77198.43%

Predictive Oncology Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	1	1	1	1	1	1	1
Gross Profit	0	0	0	0	0	0	0	1	1	0
Operating Income	-4	-6	-7	-7	-13	-12	-20	-26	-12	-10
EBITDA	-4	-6	-5	-7	-12	-11	-12	-13	-13	-10
Interest Expense	0	0	-	-	-	-	12	10	-	-
Depreciation	-	-	0	0	0	1	1	1	0	0
Income Before Tax	-4	-6	-7	-10	-19	-25	-20	-25	-13	-10
Income Tax Expense	-	-	0	-2	8	11	0	10	0	-
Net Income	-4	-6	-7	-10	-19	-25	-19	-25	-13	-12
Net Profit Margin	-732.10%	-1429.59%	-1182.98%	-714.51%	-1373.71%	-2066.99%	-1383.65%	-1709.62%	-785.58%	-751.39%

Predictive Oncology Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-3	-3	-4	-3	-3	-2	-2	-2
Operating Cash Flow	-3	-3	-3	-3	-3	-2	-3	0	-3
Investing Cash Flow	0	0	0	0	0	0	0	0	-
Financing Cash Flow	-	0	0	0	3	0	0	2	0
Change in Cash	-3	-2	-3	-3	0	-2	-2	2	-2

Predictive Oncology Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-6	-7	-10	-19	-25	-19	-25	-13	-10
Operating Cash Flow	-4	-4	-5	-8	-12	-12	-12	-13	-11
Investing Cash Flow	0	-1	-1	0	0	-10	0	0	0
Financing Cash Flow	1	5	5	9	12	50	6	0	3
Change in Cash	-3	0	0	0	0	27	-6	-13	-7

Global Institutional Holdings in Predictive Oncology Inc

Funds	Holdings
Vanguard Group Inc	0.62%
Geode Capital Management, LLC	0.55%
Virtu Financial LLC	0.14%
State Street Corp	0.12%
Carnegie Mellon University	0.09%

See all

Insights on Predictive Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, POAI has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -2.44M → -2.07M (in $), with an average increase of 18.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Tempus Ai has given 89.9% return, outperforming this stock by 96.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 611.58K → 2.68K (in $), with an average decrease of 89.8% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, POAI stock has moved down by -31.4%

About Predictive Oncology Inc

predictive oncology (nasdaq: poai) is focused on the use of data and artificial intelligence (ai) to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcome. the company has several tools that support its mission of bringing precision medicine to the diagnosis of cancer. through its subsidiaries, predictive oncology’s portfolio of assets includes the following: - a database of clinically validated historical and outcome data from patient tumors - an in-house clinical laboratory improvement amendments (clia)-certified lab - a “smart” patient-derived tumor profiling platform - an in-house bioinformatics artificial intelligence (ai) platform - a new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options - an fda-approved fluid collection and disposal system using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries

Organisation	Predictive Oncology Inc
Headquarters	91 43rd Street, Pittsburgh, PA, United States, 15201
Industry	Health Technology
CEO	Mr. Raymond F. Vennare
E-voting on shares	Click here to vote

Key Management of Predictive Oncology Inc

Name	Title
Mr. Thomas McLaughlin	Chief Investment Officer
Ms. Sara Turken J.D.	Senior VP & General Counsel
Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.	Senior Vice President of Biologics
Dr. Arlette H. Uihlein FCAP, M.D.	Senior VP of Translational Medicine & Drug Discovery and Medical Director
Mr. Raymond F. Vennare	CEO & Chairman

FAQs

What is Predictive Oncology Inc share price today?

Predictive Oncology Inc share price today is $9.35 as on October 22, 2025 at 12:36 am IST. Predictive Oncology Inc share today touched a day high of $9.55 and a low of $9.26.

What is the 52 week high and 52 week low for Predictive Oncology Inc share?

Predictive Oncology Inc share touched a 52 week high of $45.9 on January 6, 2025 and a 52 week low of $9.14 on October 20, 2025. Predictive Oncology Inc stock price today i.e. October 22, 2025 at 12:36 am IST is trending at $9.35,which is 79.63% down from its 52 week high and 2.30% up from its 52 week low.

What is Predictive Oncology Inc's market capitalisation today?

Predictive Oncology Inc market capitalisation is $0.00T as on October 22, 2025 at 12:36 am IST.

How to invest in Predictive Oncology Inc Stock (POAI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Predictive Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Predictive Oncology Inc Shares that will get you 0.1604 shares as per Predictive Oncology Inc share price of $9.35 per share as on October 22, 2025 at 12:36 am IST.

What is the minimum amount required to buy Predictive Oncology Inc Stock (POAI) from India?

Indian investors can start investing in Predictive Oncology Inc (POAI) shares with as little as ₹87.965 or $1 (as of October 22, 2025 at 12:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Predictive Oncology Inc stock (as per the Rupee-Dollar exchange rate as on October 22, 2025 at 12:37 am IST). Based on Predictive Oncology Inc share’s latest price of $9.35 as on October 22, 2025 at 12:36 am IST, you will get 1.0695 shares of Predictive Oncology Inc. Learn more about fractional shares .

What are the returns that Predictive Oncology Inc has given to Indian investors in the last 5 years?

Predictive Oncology Inc stock has given -96.22% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?